{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:05:08Z","timestamp":1789535108342,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes of Health Training Grant","award":["T32CA160003"],"award-info":[{"award-number":["T32CA160003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10549-026-08073-6","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:38:16Z","timestamp":1789533496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in contralateral prophylactic mastectomy and genetic testing in the era of new society guidelines"],"prefix":"10.1007","volume":"219","author":[{"given":"Anna M.","family":"Reagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Prathibha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Praska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Kolbow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethel","family":"Ozed-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey N.","family":"Karnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Mangino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schelomo","family":"Marmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Yuet Ching","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"6","key":"8073_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","volume":"17","author":"SM Rosenberg","year":"2013","unstructured":"Rosenberg SM, Tracy MS, Meyer ME et al (2013) Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med Sep 17(6):373\u2013381. https:\/\/doi.org\/10.7326\/0003-4819-159-6-201309170-00003","journal-title":"Ann Intern Med Sep"},{"key":"8073_CR2","doi-asserted-by":"publisher","unstructured":"Han E, Johnson N, Glissmeyer M et al (May 2011) Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg 201(5):615\u2013618. https:\/\/doi.org\/10.1016\/j.amjsurg.2011.01.018","DOI":"10.1016\/j.amjsurg.2011.01.018"},{"issue":"9793","key":"8073_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/s0140-6736(11)60993-8","volume":"27","author":"C Davies","year":"2011","unstructured":"Davies C, Godwin J, Gray R et al (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet Aug 27(9793):771\u2013784. https:\/\/doi.org\/10.1016\/s0140-6736(11)60993-8","journal-title":"Lancet Aug"},{"issue":"7","key":"8073_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/djz010","volume":"1","author":"I Kramer","year":"2019","unstructured":"Kramer I, Schaapveld M, Oldenburg HSA et al (2019) The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype. J Natl Cancer Inst Jul 1(7):709\u2013718. https:\/\/doi.org\/10.1093\/jnci\/djz010","journal-title":"J Natl Cancer Inst Jul"},{"issue":"9","key":"8073_CR5","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2024.2212","volume":"10","author":"V Giannakeas","year":"2024","unstructured":"Giannakeas V, Lim DW, Narod SA (2024) Bilateral Mastectomy and Breast Cancer Mortality. JAMA Oncol 10(9):1228\u20131236. https:\/\/doi.org\/10.1001\/jamaoncol.2024.2212","journal-title":"JAMA Oncol"},{"issue":"4","key":"8073_CR6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-024-14893-x","volume":"31","author":"P Singh","year":"2024","unstructured":"Singh P, Agnese D, Amin M et al (2024) Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol Apr 31(4):2212\u20132223. https:\/\/doi.org\/10.1245\/s10434-024-14893-x","journal-title":"Ann Surg Oncol Apr"},{"key":"8073_CR7","doi-asserted-by":"publisher","unstructured":"Portschy PR, Kuntz KM, Tuttle TM (2014) Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst Aug 106(8). https:\/\/doi.org\/10.1093\/jnci\/dju160","DOI":"10.1093\/jnci\/dju160"},{"issue":"9","key":"8073_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1200\/jco.2008.20.1681","volume":"20","author":"TM Tuttle","year":"2009","unstructured":"Tuttle TM, Jarosek S, Habermann EB et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol Mar 20(9):1362\u20131367. https:\/\/doi.org\/10.1200\/jco.2008.20.1681","journal-title":"J Clin Oncol Mar"},{"issue":"10","key":"8073_CR9","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","volume":"17","author":"K Yao","year":"2010","unstructured":"Yao K, Stewart AK, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998\u20132007. Ann Surg Oncol Oct 17(10):2554\u20132562. https:\/\/doi.org\/10.1245\/s10434-010-1091-3","journal-title":"Ann Surg Oncol Oct"},{"issue":"7","key":"8073_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1001\/jamasurg.2017.0115","volume":"1","author":"R Nash","year":"2017","unstructured":"Nash R, Goodman M, Lin CC et al (2017) State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004\u20132012. JAMA Surg Jul 1(7):648\u2013657. https:\/\/doi.org\/10.1001\/jamasurg.2017.0115","journal-title":"JAMA Surg Jul"},{"issue":"6","key":"8073_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jamasurg.2020.6664","volume":"1","author":"DW Lim","year":"2021","unstructured":"Lim DW, Metcalfe KA, Narod SA (2021) Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review. JAMA Surg Jun 1(6):569\u2013576. https:\/\/doi.org\/10.1001\/jamasurg.2020.6664","journal-title":"JAMA Surg Jun"},{"issue":"4","key":"8073_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejso.2011.12.014","volume":"38","author":"U G\u00fcth","year":"2012","unstructured":"G\u00fcth U, Myrick ME, Viehl CT, Weber WP, Lardi AM, Schmid SM (2012) Increasing rates of contralateral prophylactic mastectomy - a trend made in USA? Eur J Surg Oncol Apr 38(4):296\u2013301. https:\/\/doi.org\/10.1016\/j.ejso.2011.12.014","journal-title":"Eur J Surg Oncol Apr"},{"issue":"2","key":"8073_CR13","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.9778\/cmajo.20130025","volume":"2","author":"G Porter","year":"2014","unstructured":"Porter G, Wagar B, Bryant H et al (2014) Rates of breast cancer surgery in Canada from 2007\/08 to 2009\/10: retrospective cohort study. CMAJ Open Apr 2(2):E102\u2013E108. https:\/\/doi.org\/10.9778\/cmajo.20130025","journal-title":"CMAJ Open Apr"},{"issue":"2","key":"8073_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10549-020-05965-z","volume":"185","author":"L Findlay-Shirras","year":"2021","unstructured":"Findlay-Shirras L, Lima I, Smith G, Clemons M, Arnaout A (2021) Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study. Breast Cancer Res Treat Jan 185(2):517\u2013525. https:\/\/doi.org\/10.1007\/s10549-020-05965-z","journal-title":"Breast Cancer Res Treat Jan"},{"key":"8073_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2018.02.003","volume":"39","author":"A Fancellu","year":"2018","unstructured":"Fancellu A, Sanna V, Cottu P et al (2018) Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients. Breast Jun 39:1\u20137. https:\/\/doi.org\/10.1016\/j.breast.2018.02.003","journal-title":"Breast Jun"},{"issue":"1","key":"8073_CR16","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41598-021-82654-x","volume":"2","author":"NN Basu","year":"2021","unstructured":"Basu NN, Hodson J, Chatterjee S et al (2021) The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer. Sci Rep Feb 2(1):2847. https:\/\/doi.org\/10.1038\/s41598-021-82654-x","journal-title":"Sci Rep Feb"},{"issue":"2 Suppl","key":"8073_CR17","first-page":"73","volume":"116","author":"A Noditi","year":"2021","unstructured":"Noditi A, Caragheorghe G, Stoleru S, Blidaru A, Bordea CI (2021) Contralateral Prophylactic Mastectomy in Patients with Breast Cancer. Chirurgia (Bucur). Mar-Apr 116(2 Suppl):73\u201383","journal-title":"Mar-Apr"},{"issue":"10","key":"8073_CR18","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1245\/s10434-016-5443-5","volume":"23","author":"JC Boughey","year":"2016","unstructured":"Boughey JC, Attai DJ, Chen SL et al (2016) Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks. Ann Surg Oncol Oct 23(10):3100\u20133105. https:\/\/doi.org\/10.1245\/s10434-016-5443-5","journal-title":"Ann Surg Oncol Oct"},{"issue":"10","key":"8073_CR19","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"10","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M et al (2019) Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons. Ann Surg Oncol 10(10):3025\u20133031. https:\/\/doi.org\/10.1245\/s10434-019-07549-8. \/01 2019","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"8073_CR20","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1245\/s10434-021-09892-1","volume":"28","author":"TM Tuttle","year":"2021","unstructured":"Tuttle TM, Burke EE, Hui JYC (2021) Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy. Ann Surg Oncol Sep 28(9):4764\u20134766. https:\/\/doi.org\/10.1245\/s10434-021-09892-1","journal-title":"Ann Surg Oncol Sep"},{"issue":"10","key":"8073_CR21","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-016-5328-7","volume":"23","author":"A Chiba","year":"2016","unstructured":"Chiba A, Hoskin TL, Hallberg EJ et al (2016) Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1\/BRCA2 Mutation Carriers with Breast Cancer. Ann Surg Oncol Oct 23(10):3232\u20133238. https:\/\/doi.org\/10.1245\/s10434-016-5328-7","journal-title":"Ann Surg Oncol Oct"},{"key":"8073_CR22","doi-asserted-by":"publisher","unstructured":"Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J (2014) Preoperative genetic testing affects surgical decision making in breast cancer patients. Gynecologic Oncology. \/08\/01\/ 2014;134(2):326\u2013330. https:\/\/doi.org\/10.1016\/j.ygyno.2014.05.028","DOI":"10.1016\/j.ygyno.2014.05.028"},{"key":"8073_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13053-017-0071-z","volume":"15","author":"S Yadav","year":"2017","unstructured":"Yadav S, Reeves A, Campian S, Sufka A, Zakalik D (2017) Preoperative genetic testing impacts surgical decision making in BRCA mutation carriers with breast cancer: a retrospective cohort analysis. Hered Cancer Clin Pract 15:11. https:\/\/doi.org\/10.1186\/s13053-017-0071-z","journal-title":"Hered Cancer Clin Pract"},{"issue":"12","key":"8073_CR24","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.1245\/s10434-023-14141-8","volume":"30","author":"JQ Zhang","year":"2023","unstructured":"Zhang JQ, Dos Anjos CH, Sevilimedu V et al (2023) Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease. Ann Surg Oncol Nov 30(12):6990\u20136999. https:\/\/doi.org\/10.1245\/s10434-023-14141-8","journal-title":"Ann Surg Oncol Nov"},{"issue":"4","key":"8073_CR25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.suc.2018.03.004","volume":"98","author":"H Krontiras","year":"2018","unstructured":"Krontiras H, Farmer M, Whatley J (2018) Breast Cancer Genetics and Indications for Prophylactic Mastectomy. Surg Clin North Am Aug 98(4):677\u2013685. https:\/\/doi.org\/10.1016\/j.suc.2018.03.004","journal-title":"Surg Clin North Am Aug"},{"issue":"12","key":"8073_CR26","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1245\/s10434-023-14161-4","volume":"30","author":"TM Tuttle","year":"2023","unstructured":"Tuttle TM, Hui JYC (2023) Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA. Ann Surg Oncol Nov 30(12):6958\u20136959. https:\/\/doi.org\/10.1245\/s10434-023-14161-4","journal-title":"Ann Surg Oncol Nov"},{"issue":"9","key":"8073_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/jco.22.01239","volume":"20","author":"S Yadav","year":"2023","unstructured":"Yadav S, Boddicker NJ, Na J et al (2023) Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. J Clin Oncol Mar 20(9):1703\u20131713. https:\/\/doi.org\/10.1200\/jco.22.01239","journal-title":"J Clin Oncol Mar"},{"issue":"3","key":"8073_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.bjc.6602703","volume":"8","author":"TC van Sprundel","year":"2005","unstructured":"van Sprundel TC, Schmidt MK, Rookus MA et al (2005) Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer Aug 8(3):287\u2013292. https:\/\/doi.org\/10.1038\/sj.bjc.6602703","journal-title":"Br J Cancer Aug"},{"issue":"6","key":"8073_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/jco.2004.04.188","volume":"15","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol Mar 15(6):1055\u20131062. https:\/\/doi.org\/10.1200\/jco.2004.04.188","journal-title":"J Clin Oncol Mar"},{"key":"8073_CR30","unstructured":"Koffi JMN, Koffi KK, Bonny SB, Bi AIZ (2021) R: a language and environment for statistical computing. R foundation for statistical computing. https:\/\/www.R-project.org\/"},{"issue":"12","key":"8073_CR31","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1111\/tbj.14080","volume":"26","author":"JC Bekeny","year":"2020","unstructured":"Bekeny JC, Schreeder CA, Wirth P et al (2020) Factors contributing to persistent rates of contralateral prophylactic mastectomy in breast cancer patients: Examination of 1051 mastectomies across a single health system. Breast J Dec 26(12):2341\u20132349. https:\/\/doi.org\/10.1111\/tbj.14080","journal-title":"Breast J Dec"},{"issue":"6","key":"8073_CR32","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1245\/s10434-025-17185-0","volume":"32","author":"A Weiss","year":"2025","unstructured":"Weiss A, Rosito MS, Braun D et al (2025) Impact of the American Society of Breast Surgeons\u2019 Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates. Ann Surg Oncol Jun 32(6):3965\u20133974. https:\/\/doi.org\/10.1245\/s10434-025-17185-0","journal-title":"Ann Surg Oncol Jun"},{"issue":"3","key":"8073_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.surg.2023.09.015","volume":"175","author":"JA Steadman","year":"2024","unstructured":"Steadman JA, Hoskin TL, Klassen C et al (2024) Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. Surgery Mar 175(3):677\u2013686. https:\/\/doi.org\/10.1016\/j.surg.2023.09.015","journal-title":"Surgery Mar"},{"issue":"16","key":"8073_CR34","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1200\/jco.2010.29.4041","volume":"1","author":"TA King","year":"2011","unstructured":"King TA, Sakr R, Patil S et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol Jun 1(16):2158\u20132164. https:\/\/doi.org\/10.1200\/jco.2010.29.4041","journal-title":"J Clin Oncol Jun"},{"issue":"33","key":"8073_CR35","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1200\/jco.2007.12.3141","volume":"20","author":"TM Tuttle","year":"2007","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol Nov 20(33):5203\u20135209. https:\/\/doi.org\/10.1200\/jco.2007.12.3141","journal-title":"J Clin Oncol Nov"},{"issue":"9","key":"8073_CR36","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1245\/s10434-021-09855-6","volume":"28","author":"KA Metcalfe","year":"2021","unstructured":"Metcalfe KA, Eisen A, Poll A et al (2021) Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result. Ann Surg Oncol Sep 28(9):4967\u20134973. https:\/\/doi.org\/10.1245\/s10434-021-09855-6","journal-title":"Ann Surg Oncol Sep"},{"key":"8073_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.critrevonc.2018.09.009","volume":"132","author":"C van Marcke","year":"2018","unstructured":"van Marcke C, Collard A, Vikkula M, Duhoux FP (2018) Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data. Crit Rev Oncol Hematol Dec 132:138\u2013144. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.09.009","journal-title":"Crit Rev Oncol Hematol Dec"},{"issue":"44","key":"8073_CR38","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"1","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A Nov 1(44):18032\u201318037. https:\/\/doi.org\/10.1073\/pnas.1115052108","journal-title":"Proc Natl Acad Sci U S A Nov"},{"issue":"11","key":"8073_CR39","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-011-1914-x","volume":"18","author":"A Abbott","year":"2011","unstructured":"Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T (2011) Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol Oct 18(11):3129\u20133136. https:\/\/doi.org\/10.1245\/s10434-011-1914-x","journal-title":"Ann Surg Oncol Oct"},{"issue":"3","key":"8073_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1023\/a:1021853302033","volume":"77","author":"E Rakovitch","year":"2003","unstructured":"Rakovitch E, Franssen E, Kim J et al (2003) A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat Feb 77(3):285\u2013293. https:\/\/doi.org\/10.1023\/a:1021853302033","journal-title":"Breast Cancer Res Treat Feb"},{"issue":"1","key":"8073_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1524-4741.2007.00521.x","volume":"14","author":"A Altschuler","year":"2008","unstructured":"Altschuler A, Nekhlyudov L, Rolnick SJ et al (2008) Positive, negative, and disparate\u2013women\u2019s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J Jan-Feb 14(1):25\u201332. https:\/\/doi.org\/10.1111\/j.1524-4741.2007.00521.x","journal-title":"Breast J Jan-Feb"},{"issue":"5","key":"8073_CR42","doi-asserted-by":"publisher","first-page":"e1096","DOI":"10.1097\/sla.0000000000005920","volume":"1","author":"K Diao","year":"2023","unstructured":"Diao K, Lei X, He W et al (2023) Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction. Ann Surg Nov 1(5):e1096\u2013e1102. https:\/\/doi.org\/10.1097\/sla.0000000000005920","journal-title":"Ann Surg Nov"},{"issue":"6","key":"8073_CR43","doi-asserted-by":"publisher","first-page":"e220631","DOI":"10.1001\/jamasurg.2022.0631","volume":"1","author":"SE Hanson","year":"2022","unstructured":"Hanson SE, Lei X, Roubaud MS et al (2022) Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg Jun 1(6):e220631. https:\/\/doi.org\/10.1001\/jamasurg.2022.0631","journal-title":"JAMA Surg Jun"},{"issue":"7","key":"8073_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamasurg.2017.0458","volume":"152","author":"SJ Katz","year":"2017","unstructured":"Katz SJ, Janz NK, Abrahamse P et al (2017) Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer. JAMA Surg 152(7):658\u2013664. https:\/\/doi.org\/10.1001\/jamasurg.2017.0458","journal-title":"JAMA Surg"},{"issue":"1","key":"8073_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jamasurg.2017.3415","volume":"153","author":"SJ Katz","year":"2018","unstructured":"Katz SJ, Hawley ST, Hamilton AS et al (2018) Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer. JAMA Surg 153(1):29\u201336. https:\/\/doi.org\/10.1001\/jamasurg.2017.3415","journal-title":"JAMA Surg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08073-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:38:33Z","timestamp":1789533513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08073-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["8073"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08073-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Due to its retrospective nature, this study was granted exemption by the Institutional Review Board at both the University of Kentucky and the University of Minnesota.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"14"}}